Last reviewed · How we verify
Prostaglandin F2alpha
At a glance
| Generic name | Prostaglandin F2alpha |
|---|---|
| Also known as | Dinoprost |
| Sponsor | Danish Headache Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital (NA)
- A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma (PHASE4)
- Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men (PHASE1, PHASE2)
- Oxidoreductive Balance and Lysosomal Activity in Cancer Patients.
- Prostaglandin F2-alpha (PGF2α) in Vitiligo (NA)
- Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) (PHASE4)
- The Influence of Glycaemia and Insulinemia on Vasomotor Endothelial Function After Myocardial Infarction
- Techniques to Improve Efficacy of Second Trimester Medical Termination (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prostaglandin F2alpha CI brief — competitive landscape report
- Prostaglandin F2alpha updates RSS · CI watch RSS
- Danish Headache Center portfolio CI